Domov › Rakovina pľúc › Tennessee › Memphis
Klinické štúdie Rakovina pľúc v meste Memphis, TN
18 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste Memphis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Prebieha náborFáza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Prebieha náborFáza 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Baptist Memorial Hospital-Memphis, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Baptist Cancer Center, Memphis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Prebieha náborFáza 3
- Baptist Cancer Center, Southaven · 11 míľ odtiaľ
- West Cancer Center & Research Institute, Germantown · 14 míľ odtiaľ
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Prebieha náborFáza 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Prebieha náborFáza 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 míľ odtiaľ
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 míľ odtiaľ
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Prebieha náborVítaní zdravých dobrovoľníkov
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Memphis
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v Memphis
- Rakovina (všetky typy)31 štúdií
- Nemalobunkový karcinóm pľúc23 štúdií
- Rakovina prsníka22 štúdií
- Srpkovitá anémie18 štúdií
- Akútna lymfoblastová leukémia16 štúdií
- Akútna myeloidná leukémia15 štúdií
- Srdcové zlyhanie13 štúdií
- Sarkom měkkých tkání11 štúdií
- Melanóm11 štúdií
- Rakovina prostaty11 štúdií
- Kolorektálny karcinóm11 štúdií
- Osteosarkóm10 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.